ECTRIMS eLearning

Prevalence of Multiple Sclerosis in Quito, Ecuador
ECTRIMS Learn. Correa Díaz E. 10/25/17; 199361; EP1340
Edgar Patricio Correa Díaz
Edgar Patricio Correa Díaz
Contributions
Abstract

Abstract: EP1340

Type: ePoster

Abstract Category: Clinical aspects of MS - 5 Epidemiology

Background: Ecuador has a low prevalence of multiple sclerosis (MS). An epidemiological study conducted 10 years ago showed that the prevalence of MS in Ecuador was 1.2 / 100,000 and in the city of Quito (latitude 0) 5 / 100,000 inhabitants. Since 2007 no new epidemiological studies have been carried out and we do not know if the prevalence has increased like it has in other regions of the world.
Objectives: To determine the prevalence of multiple sclerosis in the population of Quito and to describe its epidemiological characteristics.
Methods: We performed a retrospective descriptive study from January 1, 2014 to December 31, 2016. Patients included in the study were those who met the McDonald 2010 criteria for MS and lived in the city Quito for at least one year. Patients come from three third-level hospitals; Carlos Andrade Marín, Eugenio Espejo and Militar, which are institutions of national reference for diagnosis and treatment of MS. Patients who did not live in Quito were excluded from the study.
Results: We identified a total of 101 patients with MS, with a prevalence of 4.51 / 100,000 (CI 95%, 3.63-5.39). The average age was 41.85 years old (SD +/- 12.38). 66% of the cases were women; The female to male ratio was 2: 1. Eighty-two percent of the cases were relapsing-remitting MS, 9% clinically isolated syndrome, and 9% progressive MS. The mean EDSS was 3.18 (SD +/- 2.05).
Conclusions: The prevalence of MS in the city of Quito is low and is similar to that reported 10 years ago. The disease was more frequent in women. The present study has limitations due the fact that it is not a community study and it is imperative to create a surveillance system that allows us to obtain a better patient registry.
Disclosure:
Correa Patricio: nothing to disclose
Ortiz Angélica: notihing to disclose
Torres Germain: nothing to disclose
Buestan Eugenia: nothing to disclose
Paredes Victor: nothing to disclose
Narvaez Beatriz: nothing to disclose
Arroyo Hyland: nothing to disclose
Vasconez Vanesa: nothing to disclose
Jacome Carolina: nothing to disclose
Zambrano Juan Jose: nothing to disclose

Abstract: EP1340

Type: ePoster

Abstract Category: Clinical aspects of MS - 5 Epidemiology

Background: Ecuador has a low prevalence of multiple sclerosis (MS). An epidemiological study conducted 10 years ago showed that the prevalence of MS in Ecuador was 1.2 / 100,000 and in the city of Quito (latitude 0) 5 / 100,000 inhabitants. Since 2007 no new epidemiological studies have been carried out and we do not know if the prevalence has increased like it has in other regions of the world.
Objectives: To determine the prevalence of multiple sclerosis in the population of Quito and to describe its epidemiological characteristics.
Methods: We performed a retrospective descriptive study from January 1, 2014 to December 31, 2016. Patients included in the study were those who met the McDonald 2010 criteria for MS and lived in the city Quito for at least one year. Patients come from three third-level hospitals; Carlos Andrade Marín, Eugenio Espejo and Militar, which are institutions of national reference for diagnosis and treatment of MS. Patients who did not live in Quito were excluded from the study.
Results: We identified a total of 101 patients with MS, with a prevalence of 4.51 / 100,000 (CI 95%, 3.63-5.39). The average age was 41.85 years old (SD +/- 12.38). 66% of the cases were women; The female to male ratio was 2: 1. Eighty-two percent of the cases were relapsing-remitting MS, 9% clinically isolated syndrome, and 9% progressive MS. The mean EDSS was 3.18 (SD +/- 2.05).
Conclusions: The prevalence of MS in the city of Quito is low and is similar to that reported 10 years ago. The disease was more frequent in women. The present study has limitations due the fact that it is not a community study and it is imperative to create a surveillance system that allows us to obtain a better patient registry.
Disclosure:
Correa Patricio: nothing to disclose
Ortiz Angélica: notihing to disclose
Torres Germain: nothing to disclose
Buestan Eugenia: nothing to disclose
Paredes Victor: nothing to disclose
Narvaez Beatriz: nothing to disclose
Arroyo Hyland: nothing to disclose
Vasconez Vanesa: nothing to disclose
Jacome Carolina: nothing to disclose
Zambrano Juan Jose: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies